What this study is
This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty.
A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.
Study details
- Official title
- Multicenter Prospective Registry for Periprosthetic Fractures After Hip or Knee Arthroplasty
- Sponsor
- AO Innovation Translation Center
- Conditions
- Periprosthetic Fractures · Periprosthetic Fracture Around Prosthetic Joint Implant
- Enrolling
- 600 people
- Starts
- 2018-12-31
- Est. completion
- 2027-03-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age ≥18 years
- Post-operative PPFx after total or hemi hip or total or unicondylar knee arthroplasty (including the acetabulum, femur, patella and proximal tibia) requiring
- Osteosynthesis alone or
- Component revision plus plate/nail osteosynthesis
- Informed consent obtained, i.e.:; Ability of the patient or assigned representative to understand the content of the patient information / Informed Consent Form; Signed and dated EC / IRB approved written informed consent
- Ability to attend post-operative follow up visits
You can't join if
- Pregnancy or women planning to conceive within the study period
- Prisoner
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (13)
12 openUniversity of Missouri Health Care
Columbia, Missouri, United States
- Gregory Della Rocca, MD · Contactdellaroccag@health.missouri.edu
RecruitingJersey City Medical Center RWJ Barnabas Health
Jersey City, New Jersey, United States
- Frank A. Liporace, MD · Contact2017165854liporace33@gmail.com
RecruitingSaint Barnabas Medical Center Livingston
Livingston, New Jersey, United States
- Richard S. Yoon, MD · Contact2017165847yoonrich@gmail.com
RecruitingVanderbilt University Medical Center
Nashville, Tennessee, United States
- William Obremskey, MD · ContactWilliam.Obremskey@vumc.org
Recruiting
9 sites outside the US
Universitaire Ziekenhuiven Leuven
Leuven, Belgium
- An Sermon · Contact+32 16 34 45 92an.sermon@uzleuven.be
RecruitingHospital Santa Clara
Bogotá, Colombia
- Saúl Leonardo Martínez Prieto, MD · Contact573105616266smart7406@yahoo.com
RecruitingCharité Universitätsmedizin Berlin
Berlin, Germany
- Marcel Niemann, MD · Contactmarcel.niemann@charite.de
RecruitingBG-Unfallklinik Ludwigshafen
Ludwigshafen, Germany
- Paul Grützner, MD · Contact+49 62168102311Paul.Gruetzner@bgu-ludwigshafen.de
RecruitingUniversitätsklinikum Münster
Münster, Germany
- Michael J. Raschke, MD · Contact+49 251 4841 881Michael.Raschke@uni-muenster.de
RecruitingHospital Universitario Son Llàtzer
Palma de Mallorca, Spain
- Angel Del Rio Mangada, MD · Contactario@hsll.es
Recruiting- Recruiting
Universitätsspital Zürich
Zurich, Switzerland
- Hans-Christoph Pape, MD · Contacthans-christoph.pape@usz.ch
RecruitingKantonspital Baselland
Liestal, Switzerland
Terminated
Study team
Sponsor
AO Innovation Translation Center
Study ID PPFx
Principal investigator
Karl Stoffel, MD
Universitätsspital Basel
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.